Cite
Delemarre EM, van Hoorn L, Bossink AWJ, et al. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Front Immunol. 2021;12:725447doi: 10.3389/fimmu.2021.725447.
Delemarre, E. M., van Hoorn, L., Bossink, A. W. J., Drylewicz, J., Joosten, S. A., Ottenhoff, T. H. M., Akkerman, O. W., Goletti, D., Petruccioli, E., Navarra, A., van den Broek, B. T. A., Paardekooper, S. P. A., van Haeften, I., Koenderman, L., Lammers, J. J., Thijsen, S. F. T., Hofland, R. W., & Nierkens, S. (2021). Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Frontiers in immunology, 12725447. https://doi.org/10.3389/fimmu.2021.725447
Delemarre, Eveline M, et al. "Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis." Frontiers in immunology vol. 12 (2021): 725447. doi: https://doi.org/10.3389/fimmu.2021.725447
Delemarre EM, van Hoorn L, Bossink AWJ, Drylewicz J, Joosten SA, Ottenhoff THM, Akkerman OW, Goletti D, Petruccioli E, Navarra A, van den Broek BTA, Paardekooper SPA, van Haeften I, Koenderman L, Lammers JJ, Thijsen SFT, Hofland RW, Nierkens S. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Front Immunol. 2021 Oct 07;12:725447. doi: 10.3389/fimmu.2021.725447. eCollection 2021. PMID: 34691031; PMCID: PMC8529994.
Copy
Download .nbib